Literature DB >> 15357306

Expression and purification of a recombinant scFv towards the exotoxin of the pathogen, Burkholderia pseudomallei.

Kue-Peng Lim1, Hongbin Li, Sheila Nathan.   

Abstract

A single chain variable fragment (scFv) specific towards B. pseudomallei exotoxin had previously been generated from an existing hybridoma cell line (6E6AF83B) and cloned into the phage display vector pComb3H. In this study, the scFv was subcloned into the pComb3X vector to facilitate the detection and purification of expressed antibodies. Detection was facilitated by the presence of a hemagglutinin (HA) tag, and purification was facilitated by the presence of a histidine tag. The culture was grown at 30 degrees C until log phase was achieved and then induced with 1 mM IPTG in the absence of any additional carbon source. Induction was continued at 30 degrees C for five h. The scFv was discerned by dual processes-direct enzyme-linked immunosorbent assays (ELISA), and Western blotting. When compared to E. coli strains ER2537 and HB2151, scFv expression was observed to be highest in the E. coli strain Top10F'. The expressed scFv protein was purified via nickel-mediated affinity chromatography and results indicated that two proteins a 52 kDa protein, and a 30 kDa protein were co-purified. These antibodies, when blotted against immobilized exotoxin, exhibited significant specificity towards the exotoxin, compared to other B. pseudomallei antigens. Thus, these antibodies should serve as suitable reagents for future affinity purification of the exotoxin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357306

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  4 in total

1.  Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli.

Authors:  Vajihe Akbari; Hamid Mir Mohammad Sadeghi; Abbas Jafrian-Dehkordi; Daryoush Abedi; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2014-03-27       Impact factor: 3.346

2.  Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus.

Authors:  Xiling Guo; Li Zhang; Wenshuai Zhang; Ying Chi; Xiaoyan Zeng; Xian Li; Xian Qi; Qiu Jin; Xiao Zhang; Mingming Huang; Hua Wang; Yin Chen; Changjun Bao; Jianli Hu; Shuyi Liang; Lin Bao; Tao Wu; Minghao Zhou; Yongjun Jiao
Journal:  Clin Vaccine Immunol       Date:  2013-07-17

3.  Engineering a single-chain antibody against Trypanosoma cruzi metacyclic trypomastigotes to block cell invasion.

Authors:  Lara Maria Kalempa Demeu; Rodrigo Jahn Soares; Juliana Severo Miranda; Lisandro A Pacheco-Lugo; Kelin Gonçalves Oliveira; Cristian Andrés Cortez Plaza; Philippe Billiald; Juliana Ferreira de Moura; Nobuko Yoshida; Larissa Magalhães Alvarenga; Wanderson Duarte DaRocha
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

4.  Efficient expression of EpEX in the cytoplasm of Escherichia coli using thioredoxin fusion protein.

Authors:  Farideh Rasooli; Atieh Hashemi
Journal:  Res Pharm Sci       Date:  2019-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.